Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer

Abroad (travel likely)Recruiting

Conditions

Carcinoma of Unknown Primary · Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Metastatic Head and Neck Carcinoma · Metastatic Malignant Neoplasm in the Uterine Cervix · Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Stage I Hypopharyngeal Carcinoma AJCC v8 · Stage I Nasopharyngeal Carcinoma AJCC v8 · Stage II Hypopharyngeal Carcinoma AJCC v8 · Stage II Laryngeal Cancer AJCC v8 · Stage II Nasopharyngeal Carcinoma AJCC v8 · Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage III Hypopharyngeal Carcinoma AJCC v8 · Stage III Laryngeal Cancer AJCC v8 · Stage III Nasopharyngeal Carcinoma AJCC v8 · Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage IV Hypopharyngeal Carcinoma AJCC v8 · Stage IV Laryngeal Cancer AJCC v8 · Stage IV Nasopharyngeal Carcinoma AJCC v8 · Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage IVA Hypopharyngeal Carcinoma AJCC v8 · Stage IVA Laryngeal Cancer AJCC v8 · Stage IVA Nasopharyngeal Carcinoma AJCC v8 · Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 · Stage IVB Hypopharyngeal Carcinoma AJCC v8 · Stage IVB Laryngeal Cancer AJCC v8 · Stage IVB Nasopharyngeal Carcinoma AJCC v8 · Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

M D Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (Eileen H. Shinn) · 713-745-0870
Contact: Principal Investigator (Eileen H. Shinn)

Study leads

Eileen H Shinn
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Head and Neck Carcinoma of Unknown Primary

Abroad (travel likely)RecruitingPHASE1

Tampa, United States · Chicago, United States

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Metastatic Head and Neck Squamous Cell Carcinoma · Metastatic Hypopharyngeal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1

Atlanta, United States · Atlanta, United States

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Human Papillomavirus-Related Neck Squamous Cell Carcinoma of Unknown Primary · Metastatic Head and Neck Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States · Atlanta, United States

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Metastatic Head and Neck Squamous Cell Carcinoma · Metastatic Hypopharyngeal Squamous Cell Carcinoma · Metastatic Laryngeal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE3

Little Rock, United States · Marysville, United States